Morning Briefing

Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports. According to the newspaper, "health specialists have voiced concerns about the cost and effectiveness of the technology the Cubans are selling," and the WHO "is finalizing guidance that concludes larvicides have only a 'specific and limited' role to play, where there are sites for mosquito larvae that are 'few, fixed and findable' -- something that is rarely the case in Africa."